Published in
American Society of Hematology, Blood Advances, 7(4), p. 1321-1324, 2020
DOI: 10.1182/bloodadvances.2020001553
Links
Tools
Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function
Journal article published in 2020 by
Paolo Milani 
,
Marco Basset ,
Paola Curci,
Andrea Foli ,
Rita Rizzi,
Mario Nuvolone,
Raffaella Guido,
Loreto Gesualdo,
Giorgina Specchia,
Giampaolo Merlini,
Giovanni Palladini
,
Marco Basset ,
Paola Curci,
Andrea Foli ,
Rita Rizzi,
Mario Nuvolone,
Raffaella Guido,
Loreto Gesualdo,
Giorgina Specchia,
Giampaolo Merlini,
Giovanni Palladini
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 
Abstract
Key PointsDaratumumab is effective in treated light chain deposition disease. Daratumumab can prevent progression of renal failure in these patients.